glp-1 dual agonist Machine learning designs new GCGR/GLP-1R agonists with enhanced biological potency The dual agonist action of
Description
On one hand, they offer a real chance to improve employee health, reduce long-term medical costs, and boost workplace productivity
This class of drugs mimics a hormone called glucagon-like peptide 1 (GLP-1)
Will the drug still work
Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling
Rare but severe complications include pancreatitis and gallbladder problems
2 The APA article notes that many patients discontinue treatment within a year because of side effects, cost, access issues, or other challenges, but this source does not establish mental distress as a uniform or primary reason across all patients
